| 摘要 |
A pharmaceutical composition comprising: (a) a compound of formula 1 wherein: n is 1 or 2; R1 is hydrogen, halogen, C1-4-alkyl, or O-C1-4-alkyl; R2 is hydrogen, halogen, C1-4-alkyl, or O-C1-4-alkyl; and R3 is hydrogen, C1-4-alkyl, OH, halogen, O-C1-4-alkyl, O-C1-4-alkylene-COOH, or O-C1-4-alkylene-COO-C1-4-alkyl, or an enantiomer, mixture of enantiomers, or racemate thereof, or an acid addition salt with pharmacologically acceptable acids thereof, or a solvate or hydrate thereof; and (b) another active substance 2, wherein the molar ratio of the compound of formula 1 to the active substance 2 is 1:10 to 12:1.
|
